Last reviewed · How we verify
NCT05347082
Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
NA trial testing Cholecalciferol in Postmenopausal Osteoporosis in 47 participants. Completed in 20 February 2022.
29 December 2021
Quick facts
| Lead sponsor | Hospital Regional 1o de Octubre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 47 |
| Start date | 29 April 2021 |
| Primary completion | 29 December 2021 |
| Estimated completion | 20 February 2022 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Cholecalciferol (cholecalciferol) — full drug profile →
Conditions studied
- Postmenopausal Osteoporosis — all drugs for Postmenopausal Osteoporosis →
- Postmenopause — all drugs for Postmenopause →
- Hyperparathyroidism, Secondary — all drugs for Hyperparathyroidism, Secondary →
- Hypovitaminosis D — all drugs for Hypovitaminosis D →
Sponsor
Hospital Regional 1o de Octubre
Who can join
Eligibility, female only, with Postmenopausal Osteoporosis or Postmenopause. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recently, an increase in the prevalence of hyperparathyroidism and hypovitaminosis D in postmenopause women has been occurring in Mexico and the world. Chronic exposure to the parathyroid hormone (PTH) is catabolic for the bone, worsening the state of osteoporosis. However, it is unclear whether these conditions could significantly improve bone mineral density (BMD). In the present work, it was shown that the resolution of hyperparathyroidism in postmenopausal women improves osteoporosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05347082
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cholecalciferol
Trials testing the same drug.
- NCT06847373 — Efficacy and Safety of Vitamin D Supplementation in Pediatric Patients with Obesity · NA · recruiting
- NCT06447441 — Clinical Outcomes Of Mega-dosage Supplementations Of Cholecalciferol In Critically Ill Patients With Sepsis · NA · not yet recruiting
- NCT06301178 — Effect of Vitamin D Injection on Hypertrophic Scars and Keloids · Phase 1, PHASE2 · completed
- NCT06053281 — The Role of Vitamin D in Neuroinflammatory on Drug Resistant Epilepsy · EARLY_PHASE1 · unknown
- NCT05860270 — Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis · Phase 4 · recruiting
Other recruiting trials for Postmenopausal Osteoporosis
Currently open trials in the same condition.
- NCT05010590 — Anabolic Therapy in Postmenopausal Osteoporosis · Phase 4 · active not recruiting
- NCT02822378 — Dried Plums and Bone Health in Postmenopausal Women · NA · active not recruiting
Other Hospital Regional 1o de Octubre trials
Trials by the same sponsor.
- NCT05346419 — Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients · NA · completed
- NCT05464654 — Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause · NA · completed
- NCT05346445 — Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome · NA · completed
- NCT05372224 — Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05347082 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Regional 1o de Octubre
- Last refreshed: 6 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05347082.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing